Are prostate biopsies mandatory in patients with prostate‐specific antigen increase during intravesical immuno‐ or chemotherapy for superficial bladder cancer?
Author:
Publisher
Wiley
Subject
Urology,Oncology
Reference20 articles.
1. European Association of Urology (EAU) Working Group on Oncological Urology. Guidelines on bladder cancer;Oosterlinck;Eur Urol,2002
2. Intravesical bacillus Calmette‐Guerin reduces the risk of progression in patients with superficial bladder cancer: A combined analysis of the published results of randomized clinical trials;Sylvester;J Urol,2002
3. Intravesical bacillus Calmette‐Guerin versus mitomycin C in superficial bladder cancer: Formal meta‐analysis of comparative studies on tumor progression;Bohle;Urology,2004
4. A combined analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer. European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group and the Medical Research Council Working Party on Superficial Bladder Cancer;Pawinski;J Urol,1996
5. Bacillus Calmette‐Guérin for superficial transitional cell carcinoma of the bladder;Schellhammer;J Urol,1986
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Granulomatous prostatitis after bacille Calmette-Guérin instillation resembles prostate carcinoma: A case report and review of the literature;World Journal of Clinical Cases;2023-03-26
2. Granulomatous Prostatitis after Bacille Calmette-Guérin Instillation Resembles Prostate Carcinoma: A Case Report;2022-11-15
3. Imaging Patterns of Bacillus Calmette–Guérin-Related Granulomatous Prostatitis Based on Multiparametric MRI;Korean Journal of Radiology;2022
4. Comparative prostate MRI before and after chronic granulomatous prostatitis following intravesical bacillus Calmette–Guérin therapy;Future Science OA;2021-02
5. Analysis of risk factors for post-bacillus Calmette–Guerin-induced prostatitis in patients with non-muscle invasive bladder cancer;Scientific Reports;2020-06-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3